Registration
KNIGHT CAPITOL CONSULTANTS for REGENXBIO
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Development of innovative therapies using gene therapy; biomedical research; Prescription drug user fee implementing legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT New | Chief of Staff, Senator Orrin G Hatch; Health Policy Director, Senator Orrin Hatch/HELP Committee, Judiciary Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.